Home Tags Drug discovery

Tag: drug discovery

Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges

Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges

Recent scientific advancements have made stem cell therapy an emerging and promising area of research. The establishment of stem cell banks around the globe has been growing rapidly, aimed at preserving the characteristics of the cells, preventing contamination, and...
Sample Management Specialists Win Queen's Award for Enterprise

Sample Management Specialists Win Queen’s Award for Enterprise

UK Small Business Minister Paul Scully said "This country is renowned for its entrepreneurial achievements and there is no greater showcase for it than The Queen's Awards. It is vital we celebrate the success of our businesses and recognise...
Lifebit and Boehringer Ingelheim Partnership

Lifebit and Boehringer Ingelheim Partner Up to Maximize the Value of Biobank Data for...

Computational science is revolutionizing the world in many ways. Hundreds of new fields and disciplines have emerged with countless opportunities and possibilities. The digital revolution has reached all sectors of modern society, including biomedical research and health care. Almost...

Datavant Partners with Nashville Biosciences to Accelerate Drug Discovery and Clinical Research

Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC) that leverages BioVU®, the medical center’s de-identified biobank to support biopharma research and development, and Datavant, the leader in securely connecting the world’s health data, today announced a...

Targeting CK1δ In Bladder Cancer

According to data from the US National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program, the 5-year survival rates, 2000-2016, for invasive bladder cancer were approximately 70% for localized cancer, 35% for regional, and 6% for metastatic bladder...

Broad And Sanger Reproduce CRISPR-Cas9 Genetic Knock-Out Screens In 725 Cancer Cell Line Models

A comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 genetic screens in 725 cancer models across 25 different cancer types. Scientists at the Wellcome Sanger Institute and the Broad Institute...

Crown Bioscience Teams Up With HUB To Launch Tumor Organoid Drug Development Platform

Crown Bioscience has launched a new tumor organoid drug development platform with the potential to significantly improve the predictivity and speed of preclinical drug discovery. Independently founded in 2006, Crown Bioscience, now a JSR Life Sciences company, a business unit of JSR Corporation,...

A:Head Bio AG Incorporated To Use Cerebral Organoids For CNS Drug Discovery

a:head bio AG, an Austrian biotech company focused on the development of next generation therapeutics for the treatment of brain disorders based on human cerebral organoids has recently been incorporated. The new venture is based on groundbreaking technology developed at the Institute...

NeuroOme Open Science Partnership To Develop Precision Drugs For ALS And Parkinson’s Disease

A new Canadian open science partnership will develop precision drugs for amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). A grant from Québec’s Ministry of Economy and Innovation, under its Fonds d’accélération des collaborations en santé (FACS), worth up to $2M, will...
Lab-grown liver organoids

Biobanking Science: Growing Liver Organoids From Tumor Biopsies

Hepatocellular carcinoma (HCC) is the most common form of liver cancer and causes over 700,000 deaths each year (1). The number of HCC cases has dramatically risen over the past two decades due to an increase in infectious hepatitis,...

⭐ Recently Featured

🔥 Popular Posts

X